"CeriBell operates an AI-powered brain-reading platform that can detect seizures. The system uses a disposable headband and EEG portal that allows for real-time bedside monitoring."
"CeriBell priced shares at $17 on Thursday, higher than an earlier estimated range of $14 to $16 a share, and is set to debut on Nasdaq under ticker symbol CBLL."
"According to its S-1 filing with the Securities and Exchange Commission (SEC), it had a net loss of $29.5 million on revenue of $45.2 million in 2023, but its revenue grew and losses narrowed compared to 2022."
"Medtech-focused IPOs in the United States have been all but nonexistent in recent quarters amid a broader downturn in the IPO market, yet CeriBell's debut indicates possible recovery signs."
Collection
[
|
...
]